<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03077165</url>
  </required_header>
  <id_info>
    <org_study_id>CL2-42909-016</org_study_id>
    <nct_id>NCT03077165</nct_id>
  </id_info>
  <brief_title>Dose-response Relationship Study of S42909 on Leg Ulcer Healing</brief_title>
  <official_title>A 10-week Randomized, Double-blind, Placebo-controlled, Prospective, International, Multicentre, Phase IIa Study of S42909 on Leg Ulcer Healing.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ilkos Therapeutic Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ilkos Therapeutic Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dose-response relationship study of S42909 on leg ulcer healing after oral repeated
      administration in patients with active venous leg ulcer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      S42909 is an inhibitor of β-Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidase which
      also inhibits vascular leukocyte adhesion to endothelial cells, Matrix Metalloproteinase-2
      (MMP-2) and Plasminogen Activator Inhibitor-1 (PAI-1) activity. It is proposed for
      development in the treatment of venous and mixed leg ulcers.

      This proof of concept study is a randomized, double-blind, placebo-controlled, multicenter,
      Phase IIa trial to evaluate the dose response of S42909 for the treatment of venous leg
      ulcers.

      Patients suffering from chronic venous disease and having at least one active venous leg
      ulcer will be selected at the selection visit (ASSE). One Reference Ulcer (RU) defined as the
      largest ulcer in size that is fitting the area selection criteria will be established. At
      ASSE, a first picture will be taken before cleansing and debridement and a second picture
      will be taken after cleansing and debridement. The investigator will check that the selection
      RU area is compliant with the selection criteria. Patients will start the selection period
      and will be switched from their current pharmacological and/or local treatment (if any) for
      venous leg ulcer to local wound care with sterile saline solution or sterile water,
      &quot;non-active&quot; dressings and standardized compression (same strength and type of compression).
      They will be administrated the placebo selection treatment for a period of fourteen days.

      Three (or four) working days before the inclusion visit, the participants will come to the
      site for a RU picture in order to get the RU area central measurement for inclusion visit
      (W000).

      At W000, the investigator will check that the inclusion RU area is compliant with the
      inclusion criteria. The investigator will also check that the participant is compliant with
      the selection treatment and stockings wearing.

      All participants found to be eligible for inclusion will be randomized to one of the
      following six groups - S42909: 100, 200, 400, 800 or 1200 mg per day- or placebo.

      The participants will enter a 6 weeks ambulatory Investigational Medicinal Product (IMP)
      treatment period on top of standard of care (standardized compression and local wound care
      with sterile saline solution or sterile water and &quot;non-active&quot; dressing) followed by a 2
      weeks follow-up period of standard of care only. During this period the participants will
      return to the investigator's site for intermediate visits after one week (W001), two weeks
      (W002), three weeks (W003), four weeks (W004), six weeks (W006) and eight weeks (W008).
      Participants will continue receiving standardized compression therapy and local wound care
      (sterile saline solution or sterile water and &quot;non-active&quot; dressing) until the end of the
      study (W008).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 12, 2017</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relative reduction of Reference Ulcer area after 4 weeks of treatment on top of standard of care compared with baseline Reference Ulcer area (W000) assessed during study visits</measure>
    <time_frame>Week 4</time_frame>
    <description>Compared with baseline Reference Ulcer area (W000) assessed during study visits</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>Occurring during the double-blind period of the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of laboratory parameters</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>Biochemistry, Haematology and Fasting Lipids</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">204</enrollment>
  <condition>Venous Leg Ulcer</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>S42909 dose 100 mg p.o., 50 mg bid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>S42909 dose 200 mg p.o., 100 mg bid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>S42909 dose 400 mg p.o., 200 mg bid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>S42909 dose 800 mg p.o., 400 mg bid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>S42909 dose 1200 mg p.o., 600 mg bid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group F</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo p.o. bid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S42909 100 mg</intervention_name>
    <description>50 mg Film-coated tablets per os administration, twice a day taken at the end of the morning and at evening meals.</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S42909 200 mg</intervention_name>
    <description>50 mg Film-coated tablets per os administration, twice a day taken at the end of the morning and at evening meals.</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S42909 400 mg</intervention_name>
    <description>200 mg Film-coated tablets per os administration, twice a day taken at the end of the morning and at evening meals.</description>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S42909 800 mg</intervention_name>
    <description>200 mg Film-coated tablets per os administration,twice a day taken at the end of the morning and at evening meals.</description>
    <arm_group_label>Group D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S42909 1200 mg</intervention_name>
    <description>200 mg Film-coated tablets per os administration, twice a day taken at the end of the morning and at evening meals.</description>
    <arm_group_label>Group E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Oral Tablet</intervention_name>
    <description>Matching placebo tablets, per os administration, twice a day taken at the end of the morning and at evening meals.</description>
    <arm_group_label>Group F</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Caucasian (defined for this study as having 2 Caucasian parents), men or women

          -  Age ≥ 18 years old

          -  18.5 kg/m2 ≤ BMI ≤ 45.0 kg/m2 (= Weight (kg) / height² (m²))

          -  Patients with chronic venous disease documented by imaging to detect a venous disorder
             in one or both the sub- and extra-fascial venous systems. The examination performed
             within 6 months before selection can be used.

          -  Patients with at least one active venous leg ulcer localised in the gaiter area (CEAP
             C6) diagnosed or reoccurred for more than 6 weeks and less than 2 years at selection
             and 3 cm away from other ulcers. Patients with bilateral ulcerations or multiple
             ulcerations on one or both legs are eligible for selection.

          -  Size of Reference Ulcer (defined as the largest ulcer in size that is fitting the area
             selection criteria) should be ≥ 5 cm2 and ≤ 100 cm2 at the selection visit and ≥ 4.5
             cm2 and ≤ 100 cm2 at the inclusion visit (measured by transparent sheet and confirmed
             with the digital 3D imaging device).

          -  Ankle Brachial Pressure Index (ABPI) ≥ 0.8 and ≤ 1.3 measured by Doppler ultrasound.

        Exclusion Criteria:

          -  Unlikely or unwilling to be compliant to standardized compression recommendation,
             study medication and visits, previous records of poor compliance to compression
             stockings.

          -  Inadequately controlled type 1 and type 2 diabetes with an HbA1c &gt; 8%.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eberhard Rabe, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Dermatology University of Bonn</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Monique Champagne, BPharm, MSc</last_name>
    <phone>450-680-3381</phone>
    <phone_ext>2910</phone_ext>
    <email>mchampagne@ilkostherapeutic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Center for Clinical Research Inc.</name>
      <address>
        <city>Castro Valley</city>
        <state>California</state>
        <zip>94546</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Reyzelman, Dr.</last_name>
      <phone>800-363-1069</phone>
    </contact>
    <contact_backup>
      <last_name>Julie Okwu</last_name>
      <phone>1-800-363-1069</phone>
      <email>julie@ccr-trials.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Limb Preservation Platform, Inc.</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shawn M Cazzell, DPM</last_name>
      <phone>800-714-8011</phone>
      <email>DrCazzell@LPPresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford Hospitals and Clinics</name>
      <address>
        <city>Redwood City</city>
        <state>California</state>
        <zip>94063</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Geoffrey Gurtner, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Shannon Meyer</last_name>
      <phone>650-721-1807</phone>
      <email>smeyer27@stanford.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Center for Clinical Research Inc.</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mher Vartivarian, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Kris Keolewyn</last_name>
      <phone>1-800-363-1069</phone>
      <email>Kris@ccr-trials.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Miami Hospital Wound Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hadar Lev-Tov</last_name>
    </contact>
    <contact_backup>
      <last_name>Aliette Espinosa</last_name>
      <phone>1-305-547-4282</phone>
      <email>aespinosa@med.miami.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Luke's Intermountain Research Center</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Warren Gude, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Lydia Nixt</last_name>
      <phone>208-489-4326</phone>
      <email>nixt@slhs.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center / Boston University Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alik Farber, MD</last_name>
      <phone>617-358-5372</phone>
      <email>noelle.sabatt@bmc.org</email>
    </contact>
    <contact_backup>
      <last_name>Noelle Sabbath</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitaet Innsbruck Universitaetsklinik für Gefässchirurgie</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josef KLOCKER, Dr.</last_name>
      <phone>0043 51250422587</phone>
      <email>josef.klocker@i-med.ac.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>VENEX Zentrum fuer minimal invasive Venentherapie</name>
      <address>
        <city>Wien</city>
        <zip>1080</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanja SCHULLER-PETROVIC, Dr.</last_name>
      <phone>00431408 6733</phone>
      <email>schuller-petrovic@vienna.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitaet Wien AKH- Dermatologie</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kornelia BOEHLER, Dr.</last_name>
      <phone>0043 404005832</phone>
      <email>kornelia.boehler@meduniwien.ac.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alberta Health Services</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2R 0X7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Parsons, MD</last_name>
      <phone>403-955-6966</phone>
      <email>lauriem.parsons@ahs.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Parkwood Institute</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6C 0A7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Keast, MD</last_name>
      <phone>519-685-4292</phone>
      <phone_ext>42466</phone_ext>
      <email>David.Keast@sjhc.london.on.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toronto Regional Dermatology &amp; Wound Healing Clinic</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L4Y 1A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gary Sibbald, MD</last_name>
      <phone>905-273-9892</phone>
      <email>rgarysibbald@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ottawa Hospital Civic Campus</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4E9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim Brandys, MD</last_name>
      <phone>613-761-4766</phone>
      <email>TBRANDYS@toh.on.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centrepoint Medical Center</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K2G 6E2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Robern, MD</last_name>
      <phone>613-688-0543</phone>
      <email>mrobern@magma.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>York Dermatology Center</name>
      <address>
        <city>Richmond Hill</city>
        <state>Ontario</state>
        <zip>L4C 9M7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Afsaneh Alavi, MD</last_name>
      <phone>905-883-7997</phone>
      <email>dr.alavi@afsanehalavi.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc-Antoine Despatis, MD</last_name>
      <phone>819-346-1110</phone>
      <phone_ext>13196</phone_ext>
      <email>Marc-Antoine.Despatis@USherbrooke.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>I. Dermatovenerologicka Klinika</name>
      <address>
        <city>Brno</city>
        <zip>602 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir VASKU, MUDr. CSc</last_name>
      <phone>+420 543 182 794</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nemocnice Jihlava Chirurgie A</name>
      <address>
        <city>Jihlava</city>
        <zip>586 33</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Radovan CECH, MUDr.</last_name>
      <phone>+420 567 157 495</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nemocnice Trebic Kozni oddeleni p.o.</name>
      <address>
        <city>Třebíč</city>
        <zip>674 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vera PAVLASOVA, MUDr.</last_name>
      <phone>+420 568 809 627</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nordsjaellands Hospital - Hillerod Ortopaedkirurgisk afdeling</name>
      <address>
        <city>Hillerød</city>
        <zip>3400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lise Tarnow, Prof Dr. med</last_name>
      <phone>+45 48 29 30 74</phone>
      <email>lise.tarnow@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bispebjerg Hospital Videcenter for Sarheling</name>
      <address>
        <city>Kobenhavn</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bo JORGENSEN, Dr. med</last_name>
      <phone>+45 35313531</phone>
      <phone_ext>4419</phone_ext>
      <email>bo.joergensen@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Odense Universitetshospital Sårcentret Odense</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Marie NIELSEN, Dr.</last_name>
      <phone>+4540464415</phone>
      <email>anna.marie.nielsen@rsyd.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Berlin-Buch Klinik fuer Angiologie</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Phlebologisches Studienzentrun der Ruhr-Universität Bochum im Maria-Hilf KKH</name>
      <address>
        <city>Bochum</city>
        <zip>44805</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen Klinik für Dermatologie, Venerologie und Allergologie</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Hamburg Eppendorf Institut fuer Versorgungsforschung in der Dermatologie</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Schleswig-Holstein</name>
      <address>
        <city>Lübeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitäts-Hautklinik Tübingen, Abteilung Phlebologie</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera San Giuseppe Moscati Medicina interna</name>
      <address>
        <city>Avellino</city>
        <zip>83100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria AMITRANO, Dr.</last_name>
      <phone>00390825203828</phone>
      <email>amitranomaria@virgilio.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale San Bassiano - Azienda ULSS n. 7 Pedemontana - Ambulatorio di Vulnologia</name>
      <address>
        <city>Bassano Del Grappa</city>
        <zip>36061</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Piero BAU, Dr.</last_name>
      <phone>00390424889451</phone>
      <email>piero.bau@aslbassano.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giacomo Apostolo Castelfranco Veneto - U.O. Angiologia</name>
      <address>
        <city>Castelfranco Veneto</city>
        <zip>31033</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adriana Visona, Dr.</last_name>
      <phone>00390423732867</phone>
      <email>adriana.visona@aulss2.veneto.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele-Ospedale Ferrarotto Alessi U.O.C. di Angiologia Medica</name>
      <address>
        <city>Catania</city>
        <zip>95124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giacomo FAILLA, Dr.</last_name>
      <phone>00390957436106</phone>
      <email>jacomienko@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria di Padova U.O. Angiologia - Medicina Vascolare</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giampiero Mr Dr Giampiero AVRUSCIO, Dr.</last_name>
      <phone>00390498211248</phone>
      <email>angiologia@aopd.veneto.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Neurologico Mediterraneo NEUROMED U.O.C. Chirurgia Vascolare ed Endovascolare</name>
      <address>
        <city>Pozzilli</city>
        <zip>86077</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco POMPEO, Dr.</last_name>
      <phone>00390865929584</phone>
      <email>pompeo@neuromed.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Basso Ionio ASPCZ U.O.C. Chirurgia Generale, P.O. di Soverato</name>
      <address>
        <city>Soverato</city>
        <zip>88068</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luigi BATTAGLIA, Dr.</last_name>
      <phone>00390967539213</phone>
      <email>battagliadrluigi@interfree.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Belcolle - U.O Angiologia</name>
      <address>
        <city>Viterbo</city>
        <zip>01100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giuseppe PALERMO, Dr.</last_name>
      <phone>00390761339315</phone>
      <email>ggapalermo@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ALIAN, s.r.o., Poliklinika ČK plus</name>
      <address>
        <city>Bardejov</city>
        <zip>085 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrej DZUPINA, Dr.</last_name>
      <phone>00421905271108</phone>
      <email>alian@stonline.sk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>M.M.-Angio spol. s r.o., Angiologicka ambulancia</name>
      <address>
        <city>Dunajská Streda</city>
        <zip>929 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melinda MALA, Dr.</last_name>
      <phone>00421917467396</phone>
      <email>melinda8mala@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ANGIOCARE, s.r.o.</name>
      <address>
        <city>Košice</city>
        <zip>040 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dasa KMECOVA, Dr.</last_name>
      <phone>00421556251168</phone>
      <email>dasa.kmecova@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ALIAN, s.r.o., Angiologická ambulancia</name>
      <address>
        <city>Poprad</city>
        <zip>058 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaroslav JASCUR, Dr.</last_name>
      <phone>00421948550927</phone>
      <email>jascur@centrum.sk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dermatovenerologicke oddelenie SANARE, spol. s r.o.</name>
      <address>
        <city>Svidník</city>
        <zip>089 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hana ZELENKOVA, Dr.</last_name>
      <phone>00421547882128</phone>
      <email>dost@dost.sk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MEDENA s.r.o., Angiologicka ambulancia</name>
      <address>
        <city>Trnava</city>
        <zip>917 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martina PADUCHOVA, Dr.</last_name>
      <phone>00421911364719</phone>
      <email>martina.paduchova@medena.sk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MEDIVASA, s.r.o.</name>
      <address>
        <city>Žilina</city>
        <zip>010 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Viliam BUGAN, Dr.</last_name>
      <phone>00421415110659</phone>
      <email>medivasa@slovanet.sk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fundacion Hospital de Aviles</name>
      <address>
        <city>Avilés</city>
        <zip>33402</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Javier ALVAREZ FERNANDEZ, Dr.</last_name>
      <phone>0034985563954</phone>
      <email>ljavieralvarez12@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergi BELLMUNT, Dr.</last_name>
      <phone>0034932746131</phone>
      <email>sbellmunt@vhebron.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Consorci Sanitari de Terrassa - Hospital de Terrassa</name>
      <address>
        <city>Barcelona</city>
        <zip>08227</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorenzo ALVAREZ RODRIGUEZ, Dr.</last_name>
      <phone>0034937310007</phone>
      <phone_ext>7078</phone_ext>
      <email>LRAlvarez@CST.CAT</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Getafe</name>
      <address>
        <city>Getafe</city>
        <zip>280902</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Ramon March, Dr.</last_name>
      <email>jrmarchg@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Maria Moreno</last_name>
      <phone>916247265</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital de la Cruz Roja de Madrid</name>
      <address>
        <city>Madrid</city>
        <zip>28003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lourdes REINA GUTIERREZ, Dr.</last_name>
      <phone>0034914538300</phone>
      <email>lreina@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isaac Isaac MARTÍNEZ LÓPEZ, Dr.</last_name>
      <phone>0034666395513</phone>
      <email>dr.isaacmartinez@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Asistencial Universitario</name>
      <address>
        <city>Salamanca</city>
        <zip>37007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco LOZANO SANCHEZ, Dr.</last_name>
      <phone>0034678771959</phone>
      <email>lozano@usal.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de Manises</name>
      <address>
        <city>Valencia</city>
        <zip>46940</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bader AL-RAIES, Dr.</last_name>
      <phone>'0034961845065</phone>
      <email>balraies@hospitalmanises.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Canada</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2017</study_first_submitted>
  <study_first_submitted_qc>March 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2017</study_first_posted>
  <last_update_submitted>May 11, 2018</last_update_submitted>
  <last_update_submitted_qc>May 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Varicose Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

